JRJebaraj Rathinasamy

Jebaraj Rathinasamy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jebaraj Rathinasamy has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Calcium-Modification Techniques in Calcified Coronary Artery Disease: A Systematic Review of Comparative Evidence on Procedural Success, Complications and Clinical Outcomes

    by Sundar Chidambaram, Manokar Panchanatham, Mahadevan Venkataramani, Maheshbabu Panchanatham, Jebaraj Rathinasamy, Deepchand Raja, Nithesh Kumar, Surendar Gunasekaran, Selva Prakash, Nagendra Boopathy Senguttuvan, et al.

    Background/Objectives: Severe coronary calcification complicates percutaneous coronary intervention (PCI), and several calcium-modification technologies are available, but direct randomized comparisons are limited. We reviewed the comparative evidence on procedural success, complications and clinical outcomes. Methods: Comparative studies of coronary calcium-modification techniques during PCI that reported procedural, safety or clinical outcomes were eligible. PubMed and ClinicalTrials.gov were searched in May 2025 for records published from 1 April 2015 to 1 April 2025 (PROSPERO CRD420251077471; no external funding). We included 32 publications: eight randomized trials (10 publications) and 22 observational or descriptive studies. Evidence was organized in tiers and synthesized descriptively, without pooling, because definitions were heterogeneous and event rates were low. Risk of bias in randomized trials was assessed with RoB 2 where full texts were accessible. Results: Procedural success was generally high (usually 85–100%) and major complications were uncommon, but success definitions differed, and reported dissection (0% to over 80%) and slow-flow (0% to 31.6%) rates varied widely. Most comparative data were observational. In randomized comparisons, no device consistently outperformed another for procedural success, stent expansion or minimal stent area. Clinical outcome comparisons were limited by heterogeneous endpoints and low event rates. Risk of bias was rated from full texts for five out of the eight randomized trials, none at low risk overall; ratings for the others were provisional or not possible. Conclusions: The evidence is largely observational and of low certainty, and is insufficient to establish clinically meaningful differences among most technologies. Device selection should be lesion-specific and imaging-informed, and adequately powered head-to-head trials with standardized endpoints are needed.

  • Open Access

    Decoding AGT rs(699) variant and gene expression in relation to congenital heart defects

    by Nandini Krishnamurthy, Jebaraj Rathinaswamy, Ashok Kumar, S Shuba, Devi Krishna Rb, Sanjana Murali, Revathy Kumar, Delphia Arul Anto, Maria Christina Beuna, Andrea Mary. F

    Background: Congenital Heart Defects (CHDs) are among the most common birth anomalies worldwide, with genetic and molecular factors contributing significantly to their development. The renin–angiotensin system (RAS) plays a key role in cardiovascular regulation, and polymorphisms in the angiotensinogen ( AGT ) gene, particularly rs (699) (M235T), likely influence susceptibility to CHDs. Aim: To investigate the association between the AGT rs (699) polymorphism and CHD risk in an Indian pediatric population. Methods: A case-control study was conducted involving 112 children with CHDs and 112 age- and sex-matched healthy controls. Genomic DNA was extracted and genotyped using PCR-RFLP. Genotype and allele frequencies were compared between groups to assess their association with CHD risk. Results: The TT genotype was significantly more among CHD cases (44.6%) than controls (10.7%) ( P < 0.0001), indicating a strong association with disease risk. The CT genotype also showed a significant association ( P = 0.0090; OR = 2.3750, 95% CI: 1.2411–4.5450), while the CC genotype was more prevalent in controls. Under the dominant model ( CT + TT ), individuals carrying at least one T allele had a significantly higher risk of CHD ( P < 0.0001; OR = 4.2308, 95% CI: 2.3582–7.5903). Allele frequency analysis revealed a higher T allele frequency in cases (61.6%) than controls (28.6%) ( P < 0.0001; OR = 4.0116, 95% CI: 2.7008–5.9587). Additionally, gene expression analysis indicates significant upregulation of AGT in CHD cases, with a fold change of 1.773 ( P = 0.032676), suggesting that the T allele may influence both genetic susceptibility and gene activity. Conclusion: The AGT rs (699) T allele and TT genotype are strongly associated with an increased risk of CHD. These findings suggest that AGT gene polymorphisms, potentially along with altered gene expression, may contribute to CHD pathogenesis. Although the difference in expression was minimal, it may indicate a potential role of AGT gene activity in CHD pathogenesis. However, due to the limited number of samples, no significant clinical correlation could be established between gene expression levels and specific CHD subtypes. Further studies with larger cohorts are warranted to validate these findings and explore their clinical relevance.

  • Left ventricular apical mass after myocardial infarction—not always a thrombus: a diagnostic dilemma

    by Jayanty Venkata Balasubramaniyan, Judah Nijas Arul, Jebaraj Rathinasamy, Thangavel Periyasamy

    Myxomas arising from the left ventricle (LV) are extremely rare and can be easily mistaken for a thrombus. We report a case of a 35-year-old man who presented with an acute cerebrovascular accident, having had a prior history of an anterior wall myocardial infarction 2 years back with an echocardiographic evaluation showing mild LV systolic dysfunction. His present prothrombotic workup revealed hyperhomocystinaemia and elevated levels of factor VIII. Present echocardiography revealed a mass arising from a scarred LV wall. Considering the possibility of a thrombus, he was initially started on parenteral anticoagulation. Unfortunately, consequent echocardiogram evaluation showed no reduction in size of the LV mass hence surgical removal was done. Histopathological evaluation unveiled the mass to be a myxoma.

  • Open Access

    Clinical profile and management of patients with acute pulmonary thromboembolism – a single centre, large observational study from India

    by Thoddi Ramamurthy Muralidharan, Sankaran Ramesh, Balakrishnan Vinod Kumar, Aditya V. Ruia, Mohan Kumar, Akshaya Gopalakrishnan, Gurpreet S. Johal, Amit Hooda, Rohit Malhotra, Reza Masoomi, et al.

    Acute pulmonary thromboembolism is associated with high mortality, similar to that of myocardial infarction and stroke. We studied the clinical presentation and management of pulmonary thromboembolism in the Indian population. An analysis of 140 patients who presented with acute pulmonary thromboembolism at a large volume center in India from June 2015 through December 2018 was performed. The mean age of our study population was 50 years with 59% being male. Comorbidities including deep vein thrombosis, diabetes mellitus, hypertension, and chronic obstructive pulmonary disease were present in 52.9%, 40%, 35.7% and 7.14% of patients, respectively. Out of 140 patients, 40 (28.6%) patients had massive pulmonary thromboembolism, 36 (25.7%) sub‐massive pulmonary thromboembolism, and 64 (45.7%) had low‐risk pulmonary thromboembolism. Overall, in‐hospital mortality was 25.7%. Multivariate regression analysis found chronic kidney disease and pulmonary thromboembolism severity to be the only independent risk factors. Thrombolysis was performed in 62.5% of patients with a massive pulmonary thromboembolism and 63.9% of patients with a sub‐massive pulmonary thromboembolism. In the massive pulmonary thromboembolism group, patients receiving thrombolytic therapy had lower mortality compared with patients who did not receive therapy (p=0.022), whereas this difference was not observed in patients in the sub‐massive pulmonary thromboembolism group. We conclude that patients with acute pulmonary thromboembolism in India presented more than a decade earlier than our western counterparts, and it was associated with poor clinical outcomes. Thrombolysis was associated with significantly reduced in‐hospital mortality in patients with massive pulmonary thromboembolism.


  • A study on carotid artery intima–media thickness and metabolic risk factors in overweight and obese Indian children

    by Vignatha Sajja, Dhivyalakshmi Jeevarathnam, Saji James, Jebaraj Rathinasamy

    Introduction Carotid intima–media thickness (CIMT) serves as an early marker of atherosclerosis. Data on obesity-related risk factors and their association with carotid intima–media thickness among overweight and obese children are lacking. Objectives To compare CIMT of overweight and obese children with CIMT of normal BMI children. To compare various anthropometric and metabolic risk factors associated with increased CIMT among overweight and obese children. Methods A descriptive study in a paediatric department of a tertiary care hospital including 50 age-matched normal BMI children and 50 overweight and obese children. Anthropometric data, blood pressure, CIMT (by B-mode ultrasonography), fasting blood sugar, fasting Insulin, fasting lipid profile, TSH, and FT4 were collected. HOMA-IR and fasting glucose–insulin ratio (FGIR) were calculated for insulin resistance. Cutoff for high CIMT was derived using ROC curve analysis. Results Overweight and obese children had higher mean CIMT than normal BMI children (0.5 ± 0.1 mm vs 0.34 ± 0.05 mm, respectively, P < 0.001). ROC analysis revealed 0.45 mm as the cutoff for high CIMT. Among overweight and obese children, 31 children (62%) had high CIMT. Among metabolic risk factors for increased CIMT, only FGIR was observed to be significant. Compared to overweight and obese children with normal CIMT, those with higher CIMT had low FGIR value (5.2 ± 2.2 mm vs 6.9 ± 2.6 mm, respectively, P < 0.05). Conclusion Overweight and obese children had significantly higher CIMT than controls. Even among overweight and obese children, those with increased CIMT had low FGIR (implying insulin resistance) compared to those with normal CIMT.


  • Aortic calcification in longstanding, undiagnosed Takayasu arteritis

    by Mahesh Janarthanan, Jebaraj Rathinasamy


  • Open Access

    Normal reference ranges for aortic diameters in preterm infants

    by Lulu Abushaban, Thinakar Vel Mariappa, Jebaraj Rathinasamy, Prem N. Sharma

    X Objective: To establish normal reference ranges and Z-scores for aortic diameters in preterm infants according to the body surface area and assess their correlation with body weight, body surface area, and gestational age. Patients and methods: In a prospective study, 268 preterm infants who fulfilled the criteria for inclusion were examined. Echocardiograms were performed to measure the ascending aorta, transverse aorta, and aortic isthmus diameters on 0 days to 6 days of life and at weekly intervals until the babies reached 36 weeks. Body surface area was divided into 13 groups from 0.07 m(2) to 0.19 m(2). Results: The mean gestational age was 29.8 [p 2.38 standard deviation (SD)] weeks, ranging from 24 weeks to 35 weeks. The mean body weight was 1479 (p 413 SD) g, ranging from 588 g to 3380 g, and the mean body surface area was 0.13 m(2), ranging from 0.07 m(2) to 0.19 m(2). All the aortic diameters correlated well with both body weight and body surface area. Reference ranges with the mean p SD, range, and Z-scores were calculated for aortic diameters according to the body surface area. A significant gradual increase was observed in ascending aorta, transverse aorta, and aortic isthmus diameters with increasing body surface area. Overall, a progressive and significant increase in ascending aorta, transverse aorta, and aortic isthmus diameters was observed during the first 9 weeks of life. Conclusion: The ascending aorta, transverse aorta, and aortic isthmus diameters exhibited a significant correlation with the body surface area and body weight. This study provides reference data with Z-scores that can be used as a normal reference tool for the ascending aorta, transverse aorta, and aortic isthmus diameters for preterm infants based on the body surface area. (C) 2017 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.

  • Open Access

    Normal reference ranges for cardiac valve cross-sectional areas in preterm infants

    by Lulu Abushaban, Mariappa Thinakar Vel, Jebaraj Rathinasamy, Prem N Sharma

    Objective : To establish normal reference ranges for cardiac valve crosssectional areas (CSAs) in preterm infants and their correlation with gestational age, body weight, and chronological age. Materials and Methods : In a prospective study, 268 preterm babies fulfilling the criteria for inclusion were examined. Echocardiograms were performed to measure aortic, pulmonary, mitral, and tricuspid valve CSAs on 0–6 day (s) of life and at weekly intervals until they reached 36 weeks. Gestational age was divided into three groups, 24–27, 28–31, and 32–35 weeks, and body weight was divided into five groups, ≤999, 1000–1499, 1500–1999, 2000–2499, and ≥2500 g. Overall group differences were compared for each period of life: 0–6 days and 1–2, 3–4, and ≥5 weeks. Results : The mean gestational age was 29.8 (±2.38 standard deviation [SD]) weeks, ranging between 24 and 35 weeks, and the mean body weight was 1479 (±413 SD) g, ranging between 588 and 3380 g. All cardiac valve CSAs correlated well with body weight. A significant gradual increase was observed in all valve CSAs with body weight during each period of life. Overall, a progressive and significant increase in all valve CSAs was observed during the first 9 weeks of life. Conclusions : Cardiac valve CSAs were found to be significantly correlated with body weight. The study also provides reference data, which can be used as a normal reference tool for valve CSAs in preterm infants against gestational age, body weight, and chronological age.


  • Normal Reference Ranges for Pulmonary Artery Diameters in Preterm Infants

    by Lulu Abushaban, Mariappa Thinakar Vel, Jebaraj Rathinasamy, Prem N. Sharma

    To establish normal reference ranges and Z-scores for pulmonary artery diameters in preterm infants and their correlation with body surface area, body weight, and chronological age. In a prospective study, 268 preterm infants, who fulfilled the inclusion criteria were examined. Echocardiograms were performed to measure the main pulmonary artery, right pulmonary artery, and left pulmonary artery diameters on day(s) 0 to −6 of life and at weekly intervals until they reached 36 weeks of age. Body surface area was divided into thirteen groups from 0.07 to 0.19 m2. The mean gestational age was 29.8 (±2.38 SD) weeks, ranging between 24 and 35, the mean body weight was 1479 (±413 SD) grams, ranging between 588 and 3380, and the mean body surface area was 0.13 m2, ranging between 0.07 and 0.19 m2. All the pulmonary artery diameters correlated well with both body weight and body surface area. Reference ranges, with mean ± SD, range, and Z-scores for aortic diameters according to body surface area were calculated. A significant gradual increase was observed in main and branch pulmonary artery diameters with increasing body surface area. Overall, a progressive and significant increase for main and branch pulmonary artery diameters was observed during the first nine weeks of life. The main and branch pulmonary artery diameters were found to have significant correlation with body surface area. The study also provides reference data with Z-scores, which can be used as a normal reference tool for measuring the main pulmonary artery, right, and left pulmonary artery diameters of preterm infants against body surface area.


  • Normal Reference Ranges for Cardiac Valve Annulus in Preterm Infants

    by Lulu Abushaban, Mariappa Thinakar Vel, Jebaraj Rathinasamy, Prem N. Sharma

    The purpose of this study was to establish normal reference ranges for the cardiac valve annulus size in preterm infants and their correlation with gestational age, body weight and chronological age. In a prospective study, 268 pre-term babies, who fulfilled the criteria for inclusion, were examined in Kuwait during the years 2008–2010. Echocardiograms were performed to measure the aortic, pulmonary, mitral and tricuspid valve annulus size on 0–6 day(s) of life and at weekly intervals until they reached 36 weeks. The gestational age was grouped into three: 24–27, 28–31 and 32–35 weeks, and body weight into five: ≤999, 1000–1499, 1500–1999, 2000–2499 and ≥2500 g. The overall group differences were compared for each period of life: 0–6 days, 1–2, 3–4 and ≥5 weeks. The mean gestational age was 29.8 (±2.38 SD) weeks, ranging between 24 and 35, and the mean body weight 1479 (±413 SD) grams, ranging between 588 and 3380. At the first scan (0–6 days of life), all cardiac valve measurements correlated well with both body weight and gestational age (P < 0.001). In the subsequent weeks valve diameters correlated well with body weight, while gestational age was found to have significant correlation (P < 0.01) with aortic and mitral valves only. A significant gradual increase was noticed in all valve annulus measurements with body weight during each period of life. Overall, a progressive and significant increase for all four cardiac valve annulus measurements was observed during the first nine weeks of life. The cardiac valve annulus measurements were found to have significant correlation with body weight. All the cardiac valve measurements correlated well with gestational age (P < 0.01) only up to 2 weeks. The study also provides reference data, which can be used as a normal reference tool for cardiac valve diameters for preterm infants against the gestational age, body weight and chronological age.